September 2025- Allele Biotechnology Awarded U.S. Patent for Antibody and T-Cell Receptor Fragment Identification Method
San Diego, CA — Allele Biotechnology & Pharmaceuticals, Inc. (Allele), a San Diego-based biotechnology company and the first US company to have worked on the development of camelid antibodies, today announced the issuance of U.S. Patent No. 12,404,552 by the United States Patent and Trademark Office (USPTO) on a novel process of finding affinity fragments…